Copyright Reports & Markets. All rights reserved.

Global Canine Arthritis Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue
  • 1.4 Market 3
    • 1.4.1 Global Canine Arthritis Treatment Market Size Growth Rate 3: 2020 VS 2026
    • 1.4.2 Non-Steroidal Anti-Inflammatory Drugs
    • 1.4.3 Opioids
  • 1.5 Market by Application
    • 1.5.1 Global Canine Arthritis Treatment Market Share 4: 2020 VS 2026
    • 1.5.2 Veterinary Hospitals and Clinics
    • 1.5.3 Drug Stores
    • 1.5.4 E-commerce
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Canine Arthritis Treatment Market Perspective (2015-2026)
  • 2.2 Global Canine Arthritis Treatment Growth Trends by Regions
    • 2.2.1 Canine Arthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Canine Arthritis Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Canine Arthritis Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Canine Arthritis Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Canine Arthritis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Canine Arthritis Treatment Players by Market Size
    • 3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Canine Arthritis Treatment Market Concentration Ratio
    • 3.2.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2019
  • 3.3 Canine Arthritis Treatment Key Players Head office and Area Served
  • 3.4 Key Players Canine Arthritis Treatment Product Solution and Service
  • 3.5 Date of Enter into Canine Arthritis Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size 3 (2015-2026)

  • 4.1 Global Canine Arthritis Treatment Historic Market Size 3 (2015-2020)
  • 4.2 Global Canine Arthritis Treatment Forecasted Market Size 3 (2021-2026)

5 Market Size 4 (2015-2026)

  • 5.1 Global Canine Arthritis Treatment Market Size 4 (2015-2020)
  • 5.2 Global Canine Arthritis Treatment Forecasted Market Size 4 (2021-2026)

6 North America

  • 6.1 North America Canine Arthritis Treatment Market Size (2015-2020)
  • 6.2 Canine Arthritis Treatment Key Players in North America (2019-2020)
  • 6.3 North America Canine Arthritis Treatment Market Size 3 (2015-2020)
  • 6.4 North America Canine Arthritis Treatment Market Size 4 (2015-2020)

7 Europe

  • 7.1 Europe Canine Arthritis Treatment Market Size (2015-2020)
  • 7.2 Canine Arthritis Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Canine Arthritis Treatment Market Size 3 (2015-2020)
  • 7.4 Europe Canine Arthritis Treatment Market Size 4 (2015-2020)

8 China

  • 8.1 China Canine Arthritis Treatment Market Size (2015-2020)
  • 8.2 Canine Arthritis Treatment Key Players in China (2019-2020)
  • 8.3 China Canine Arthritis Treatment Market Size 3 (2015-2020)
  • 8.4 China Canine Arthritis Treatment Market Size 4 (2015-2020)

9 Japan

  • 9.1 Japan Canine Arthritis Treatment Market Size (2015-2020)
  • 9.2 Canine Arthritis Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Canine Arthritis Treatment Market Size 3 (2015-2020)
  • 9.4 Japan Canine Arthritis Treatment Market Size 4 (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Canine Arthritis Treatment Market Size (2015-2020)
  • 10.2 Canine Arthritis Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Canine Arthritis Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Canine Arthritis Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Canine Arthritis Treatment Market Size (2015-2020)
  • 11.2 Canine Arthritis Treatment Key Players in India (2019-2020)
  • 11.3 India Canine Arthritis Treatment Market Size by Type (2015-2020)
  • 11.4 India Canine Arthritis Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Canine Arthritis Treatment Market Size (2015-2020)
  • 12.2 Canine Arthritis Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Canine Arthritis Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Canine Arthritis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Elanco (Eli Lilly and Company)
    • 13.1.1 Elanco (Eli Lilly and Company) Company Details
    • 13.1.2 Elanco (Eli Lilly and Company) Business Overview
    • 13.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction
    • 13.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2015-2020))
    • 13.1.5 Elanco (Eli Lilly and Company) Recent Development
  • 13.2 Boehringer Ingelheim
    • 13.2.1 Boehringer Ingelheim Company Details
    • 13.2.2 Boehringer Ingelheim Business Overview
    • 13.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction
    • 13.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim Recent Development
  • 13.3 Zoetis Inc
    • 13.3.1 Zoetis Inc Company Details
    • 13.3.2 Zoetis Inc Business Overview
    • 13.3.3 Zoetis Inc Canine Arthritis Treatment Introduction
    • 13.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.3.5 Zoetis Inc Recent Development
  • 13.4 Vetoquinol S.A.
    • 13.4.1 Vetoquinol S.A. Company Details
    • 13.4.2 Vetoquinol S.A. Business Overview
    • 13.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction
    • 13.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.4.5 Vetoquinol S.A. Recent Development
  • 13.5 Bayer AG
    • 13.5.1 Bayer AG Company Details
    • 13.5.2 Bayer AG Business Overview
    • 13.5.3 Bayer AG Canine Arthritis Treatment Introduction
    • 13.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.5.5 Bayer AG Recent Development
  • 13.6 Aratana Therapeutics Inc
    • 13.6.1 Aratana Therapeutics Inc Company Details
    • 13.6.2 Aratana Therapeutics Inc Business Overview
    • 13.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction
    • 13.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.6.5 Aratana Therapeutics Inc Recent Development
  • 13.7 Norbrook Laboratories Limited
    • 13.7.1 Norbrook Laboratories Limited Company Details
    • 13.7.2 Norbrook Laboratories Limited Business Overview
    • 13.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction
    • 13.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.7.5 Norbrook Laboratories Limited Recent Development
  • 13.8 VetStem Biopharma
    • 13.8.1 VetStem Biopharma Company Details
    • 13.8.2 VetStem Biopharma Business Overview
    • 13.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction
    • 13.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.8.5 VetStem Biopharma Recent Development
  • 13.9 Dechra Pharmaceuticals Plc
    • 13.9.1 Dechra Pharmaceuticals Plc Company Details
    • 13.9.2 Dechra Pharmaceuticals Plc Business Overview
    • 13.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction
    • 13.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2015-2020)
    • 13.9.5 Dechra Pharmaceuticals Plc Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Canine Arthritis Treatment market is segmented 3, and 4. Players, stakeholders, and other participants in the global Canine Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast 3 and 4 in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Elanco (Eli Lilly and Company)
    Boehringer Ingelheim
    Zoetis Inc
    Vetoquinol S.A.
    Bayer AG
    Aratana Therapeutics Inc
    Norbrook Laboratories Limited
    VetStem Biopharma
    Dechra Pharmaceuticals Plc

    Market segment 3, the product can be split into
    Non-Steroidal Anti-Inflammatory Drugs
    Opioids
    Market segment 4, split into
    Veterinary Hospitals and Clinics
    Drug Stores
    E-commerce

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now